These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

128 related articles for article (PubMed ID: 22511820)

  • 1. Tackling influenza in Ghana. Interview by Ben Jones.
    Ampofo W
    Bull World Health Organ; 2012 Apr; 90(4):254-5. PubMed ID: 22511820
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Swine flu outbreak. Worries about Africa as pandemic marches on.
    Enserink M
    Science; 2009 Aug; 325(5941):662. PubMed ID: 19661390
    [No Abstract]   [Full Text] [Related]  

  • 3. Plotting a route to a universal influenza vaccine.
    The Lancet Infectious Diseases
    Lancet Infect Dis; 2018 May; 18(5):475. PubMed ID: 29695350
    [No Abstract]   [Full Text] [Related]  

  • 4. Pandemic flu: from the front lines. Interviewed by Declan Butler.
    Bertozzi S; Kelso A; Tashiro M; Savy V; Farrar J; Osterholm M; Jameel S; Muller CP
    Nature; 2009 Sep; 461(7260):20-1. PubMed ID: 19727174
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Children with special health care needs and preparedness: experiences from seasonal influenza and the 2009 H1N1 influenza pandemic.
    Peacock G; Moore C; Uyeki T
    Disaster Med Public Health Prep; 2012 Jun; 6(2):91-3. PubMed ID: 22700014
    [No Abstract]   [Full Text] [Related]  

  • 6. Pandemic response in low-resource settings requires effective syndromic surveillance.
    Paterson BJ; Durrheim DN; Hardie K
    Influenza Other Respir Viruses; 2013 Nov; 7(6):887-8. PubMed ID: 23462032
    [No Abstract]   [Full Text] [Related]  

  • 7. [Influenza A Beijing is approaching. 2 new strains in this season's vaccine].
    Grandien M; Linde A
    Lakartidningen; 1993 Nov; 90(44):3881-3. PubMed ID: 8231547
    [No Abstract]   [Full Text] [Related]  

  • 8. Recommendations pertaining to the use of viral vaccines: influenza 2012.
    Schoub BD
    S Afr Med J; 2012 Jan; 102(2):73. PubMed ID: 22310432
    [No Abstract]   [Full Text] [Related]  

  • 9. Improving influenza surveillance in sub-Saharan Africa.
    Steffen C; Debellut F; Gessner BD; Kasolo FC; Yahaya AA; Ayebazibwe N; Bassong O; Cardoso Y; Kebede S; Manoncourt S; Vandemaele KA; Mounts AW
    Bull World Health Organ; 2012 Apr; 90(4):301-5. PubMed ID: 22511827
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Perspective: Ill prepared for a pandemic.
    Stöhr K
    Nature; 2014 Mar; 507(7490):S20-1. PubMed ID: 24611175
    [No Abstract]   [Full Text] [Related]  

  • 11. Preparing for the Next Influenza Pandemic: The Development of a Universal Influenza Vaccine.
    Crank MC; Mascola JR; Graham BS
    J Infect Dis; 2019 Apr; 219(Suppl_1):S107-S109. PubMed ID: 30715413
    [No Abstract]   [Full Text] [Related]  

  • 12. Universal influenza vaccines: a realistic option?
    de Vries RD; Altenburg AF; Rimmelzwaan GF
    Clin Microbiol Infect; 2016 Dec; 22 Suppl 5():S120-S124. PubMed ID: 27130671
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Influenza Vaccines: Good, but We Can Do Better.
    Paules CI; Fauci AS
    J Infect Dis; 2019 Apr; 219(Suppl_1):S1-S4. PubMed ID: 30715469
    [No Abstract]   [Full Text] [Related]  

  • 14. Influenza: options to improve pandemic preparation.
    Rappuoli R; Dormitzer PR
    Science; 2012 Jun; 336(6088):1531-3. PubMed ID: 22723412
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Vaccine effectiveness and coverage against the 2009 pandemic influenza in Ghana and Malawi.
    Sambala EZ
    Disaster Med Public Health Prep; 2015 Apr; 9(2):120. PubMed ID: 25882117
    [No Abstract]   [Full Text] [Related]  

  • 16. Unlicensed pandemic influenza A H1N1 vaccines.
    Caplan AL
    Lancet; 2010 Feb; 375(9713):444-5. PubMed ID: 19914708
    [No Abstract]   [Full Text] [Related]  

  • 17. Recommended composition of the 2006/07 influenza vaccine.
    Euro Surveill; 2006 Mar; 11(3):E060330.2. PubMed ID: 16804238
    [No Abstract]   [Full Text] [Related]  

  • 18. Strengths and limitations of assessing influenza vaccine effectiveness using routinely collected, passive surveillance data in Ontario, Canada, 2007 to 2012: balancing efficiency versus quality.
    Savage RD; Winter AL; Rosella LC; Olsha R; Gubbay JB; Skowronski DM; Crowcroft NS
    Euro Surveill; 2015 Apr; 20(16):. PubMed ID: 25953275
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Considerations for the rapid deployment of vaccines against H7N9 influenza.
    Chua BY; Brown LE; Jackson DC
    Expert Rev Vaccines; 2014 Nov; 13(11):1327-37. PubMed ID: 25017993
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Reflections on pandemic (H1N1) 2009 and the international response.
    Leung GM; Nicoll A
    PLoS Med; 2010 Oct; 7(10):. PubMed ID: 20957189
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.